Phases

Phases is developing the first full-stack AI agent platform to automate clinical trials for pharmaceutical companies, initially focusing on the critical bottleneck of patient recruitment. Their AI agent, Polly, helps research sites find, interview, and schedule patients, integrating seamlessly with existing tools. This solution aims to accelerate drug development by addressing the significant delays and costs associated with traditional recruitment methods, which often involve manual record reviews and lengthy screening calls. Phases envisions building a digital workforce for clinical research, allowing teams to concentrate on patient care rather than administrative tasks, ultimately speeding up the delivery of life-saving drugs.